46
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE Causation and Prevention

Association Between the Length of a CA Dinucleotide Repeat in the EGFR and Risk of Breast Cancer

, , &
Pages 434-437 | Published online: 11 Jun 2009

REFERENCES

  • Peto R. UK and USA breast cancer deaths down 25% in year 2000 at ages of 20–69 years. Lancet 2000; 355: 1822
  • Lipworth I. Epidemiology of breast cancer. Eur J Cancer Prev 1995; 4: 7–30
  • Sondik E. Breast cancer trends: Incidence, mortality and survival. Cancer 1994; 74: 995–9
  • Lin S., Phan J., Lin A. Breast cancer characteristics of Vietnamese women in the Greater San Francisco Bay Area. West J Med 2002; 176: 87–91
  • Harirchi I., Ebrahimi M., Zamani N., Jarvandi S., Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health 2000; 114: 143–5
  • Ebrahimi M., Vahdaninia M., Montazeri A. Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res 2002; 4(5)10
  • Jorrissen R. N., Walker F., Pouliot N., Garrett T. P. J., Ward C. W., Burgess A. W. Epidermal growth factor receptor: mechanisms of activation and signaling. Exp Cell Res 2003; 284: 31–53
  • Baselga J. Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy. The Oncologist 2002; 7(4)2–8
  • Nair P. Epidermal growth factor receptor family and its role in cancer progression. Curr Sci 2005; 88: 890–8
  • Henson E. S., Gibson S. B. Surviving cell death through epidermal growth factor signal transduction pathways: Implications for cancer therapy. Cell Sig 2006; 12: 2089–97
  • Yarden Y. The EGFR family and its ligands in human cancer: signaling mechanisms and therapeutic opportunities. Eur J Cancer 2001; 37: 3–8
  • Chi D. D., Hing A. V., Helms C., Steinbrueck T., Mishra S. K., Donis-Keller H. Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro2 (1) collagen (COL1A2). Hum Mol Genet 1992; 1: 135
  • Gill G., Kawamoto T. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 1984; 259: 7755–60
  • Gebhardt F., Zänker K. S., Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron. J Biol Chem 1990; 274: 13176–80
  • Brandt B., Hermann S., Straif K., Tidow N., Buerger H., Chang J. Modification of Breast Cancer Risk in Yong Women by a Polymorphic sequence in the egfr Gene. Cancer Res 2004; 64: 7–12
  • Liu W., Innocenti F., Chen P., Das S., Cook E. J., Ratain M. J. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 2003; 9: 1009–12
  • Kang D., Gridly G., Huang W., Lawrence S. Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-a (TGFA) gene and risk of oral cancer in Puerto Rico. Pharmacog and Genom 2005; 15: 343–7
  • Welnicka M., Zaczek A., Brandt B., et al. (CA)n Microsatellite polymorphism of ERBB1 in breast cancer. Eur J Cancer 2006; 42: 1698–701
  • Brandt B., Meyer-Staeckling S., Schmidt H., Agelopoulos K., Buerger H. Mechanisms of egfr gene transcription modulation: Relationship to cancer risk and therapy response. Clin Cancer Res 2006; 12: 7252–60
  • Buerger H., Gebhardt F., Schmidt H., Beckmann A., Hutmacher K., Simon R., Lelle R., Boecker W., Brandt B. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res 2000; 60: 854–7
  • Zhang W., Weissfeld J. L., Romkes M., Land S. R., Grandis J. R., Siegfried J. M. Association of the EGFR intron 1 CA repeat length with lung cancer risk. Mol Carcinog 2007; 5: 372–80
  • Buerger H., Packeisen J., Boecker A., Tidow N., Kersting C., Bielawski K., Isola J., Yatabe Y., Nakachi K., Boecker W., Brandt B. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence—first results of an inter-ethnic breast cancer study. J Pathol 2004; 203: 545–50
  • Lee S. J., Kim K. M., Chae M. H., Lee W. K., Kam S., Cha S. I., Han H. S., Kim C. H., Kang Y. M., Han S. B., Park J. Y. No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer. Cancer Genet Cytogenet 2007; 172(1)29–32
  • McKay J. A., Murray L. J., Curran S., Ross V. G., Clark C., Murray G. I., Cassidy J., McLeod H. L. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer 2002; 17: 2258–64
  • Amador M. L., Oppenheimer D., Perea S., Maitra A., Cusati G., Iacobuzio-Donahue C., Baker S. D., Ashfaq R., Takimoto C., Forastiere A., Hidalgo M. An Epidermal Growth Factor Receptor Intron Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors. Cancer Res 2004; 64: 9139–9143
  • Etienne-Grimaldi M. C., Pereira S., Mange N., Formento J. L., Francoual M., Fontana X., Demard F., Dassonville O., Poissonnet G., Santini J., Bensadoun R. J., Szepetowski P., Milano G. Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Ann Oncol 2005; 16: 934–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.